Altogether, these data suggested that SMYD2 participates in breast cancer metastasis development, and to directly investigate this possibility, we utilized the MMTV-PyMT mouse model which develops spontaneous mammary tumors that recapitulate the tumor stages, pathology, metastasis, and biomarkers of patients with metastatic breast cancer27. This evidence concerns the gene SMYD2 and breast carcinoma.